Linmao Sun

1.1k total citations
13 papers, 242 citations indexed

About

Linmao Sun is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Linmao Sun has authored 13 papers receiving a total of 242 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Cancer Research and 4 papers in Immunology. Recurrent topics in Linmao Sun's work include RNA modifications and cancer (5 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Immune cells in cancer (3 papers). Linmao Sun is often cited by papers focused on RNA modifications and cancer (5 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Immune cells in cancer (3 papers). Linmao Sun collaborates with scholars based in China and United States. Linmao Sun's co-authors include Lianxin Liu, Jiabei Wang, Shuhang Liang, Hongrui Guo, Xianying Li, Shugeng Zhang, Yao Liu, Ning Zhang, Kun Ma and Tianming Cui and has published in prestigious journals such as Cancer Research, Oncogene and Cell Death and Differentiation.

In The Last Decade

Linmao Sun

13 papers receiving 240 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Linmao Sun China 9 89 79 64 46 46 13 242
Jiangming Chen China 11 109 1.2× 82 1.0× 81 1.3× 11 0.2× 31 0.7× 40 380
Ping Xing China 10 106 1.2× 87 1.1× 44 0.7× 42 0.9× 42 0.9× 17 387
Huafeng Wang China 9 80 0.9× 37 0.5× 75 1.2× 14 0.3× 123 2.7× 25 311
Mengping Long China 11 150 1.7× 64 0.8× 49 0.8× 17 0.4× 70 1.5× 34 333
Mingyu Zhu China 12 74 0.8× 51 0.6× 57 0.9× 45 1.0× 54 1.2× 19 308
Zhongwei Lv China 11 101 1.1× 33 0.4× 58 0.9× 51 1.1× 51 1.1× 38 403
Heng Zhao China 10 197 2.2× 142 1.8× 57 0.9× 34 0.7× 47 1.0× 19 360
Mengyang Li China 11 174 2.0× 69 0.9× 78 1.2× 13 0.3× 149 3.2× 31 398
Haiqing Jie China 7 193 2.2× 128 1.6× 59 0.9× 15 0.3× 82 1.8× 13 338
Yudong Qiu China 11 79 0.9× 56 0.7× 125 2.0× 11 0.2× 70 1.5× 34 345

Countries citing papers authored by Linmao Sun

Since Specialization
Citations

This map shows the geographic impact of Linmao Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linmao Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linmao Sun more than expected).

Fields of papers citing papers by Linmao Sun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linmao Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linmao Sun. The network helps show where Linmao Sun may publish in the future.

Co-authorship network of co-authors of Linmao Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Linmao Sun. A scholar is included among the top collaborators of Linmao Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linmao Sun. Linmao Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Zhou, Shuo, Yao Liu, Ning Zhang, et al.. (2025). Glycolytic enzyme PFKFB4 governs lipolysis by promoting de novo lipogenesis to drive the progression of hepatocellular carcinoma. Cancer Letters. 626. 217774–217774. 2 indexed citations
2.
Guo, Xinyu, Tianming Cui, Linmao Sun, et al.. (2024). A STT3A-dependent PD-L1 glycosylation modification mediated by GMPS drives tumor immune evasion in hepatocellular carcinoma. Cell Death and Differentiation. 32(5). 944–958. 12 indexed citations
3.
Ma, Kun, Yufeng Liu, Linmao Sun, et al.. (2024). Hepatocellular Carcinoma LINC01116 Outcompetes T Cells for Linoleic Acid and Accelerates Tumor Progression. Advanced Science. 11(21). e2400676–e2400676. 14 indexed citations
4.
Fei, Mingming, Xianying Li, Shuhang Liang, et al.. (2024). LncRNA PWRN1 inhibits the progression of hepatocellular carcinoma by activating PKM2 activity. Cancer Letters. 584. 216620–216620. 15 indexed citations
5.
Li, Xianying, Shuhang Liang, Mingming Fei, et al.. (2024). LncRNA CRNDE Drives the Progression of Hepatocellular Carcinoma by inducing the Immunosuppressive Niche. International Journal of Biological Sciences. 20(2). 718–732. 9 indexed citations
6.
Guo, Xinyu, Linmao Sun, Tianming Cui, et al.. (2024). Exploring the role of the immune microenvironment in hepatocellular carcinoma: Implications for immunotherapy and drug resistance. eLife. 13. 12 indexed citations
7.
Guo, Xinyu, Linmao Sun, Tianming Cui, et al.. (2024). Exploring the Interplay of Diet, Obesity, Immune Function, and Cancer. Cancer Discovery. 14(11). 2047–2050. 2 indexed citations
8.
Wang, Jiabei, Yunguang Zhang, Linmao Sun, & Yao Liu. (2023). IMMT promotes hepatocellular carcinoma formation via PI3K/AKT/mTOR pathway. ONCOLOGIE. 25(6). 691–703. 2 indexed citations
9.
Wang, Jiabei, Linmao Sun, Yao Liu, & Yunguang Zhang. (2023). FIGNL1 Promotes Hepatocellular Carcinoma Formation via RemodelingECM-receptor Interaction Pathway Mediated by HMMR. Current Gene Therapy. 24(3). 249–263. 6 indexed citations
10.
11.
Liang, Shuhang, Hongrui Guo, Kun Ma, et al.. (2021). A PLCB1–PI3K–AKT Signaling Axis Activates EMT to Promote Cholangiocarcinoma Progression. Cancer Research. 81(23). 5889–5903. 63 indexed citations
13.
Luo, Huoling, Dalong Yin, Shugeng Zhang, et al.. (2019). Augmented reality navigation for liver resection with a stereoscopic laparoscope. Computer Methods and Programs in Biomedicine. 187. 105099–105099. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026